Status:
RECRUITING
The Short-term Effects of PRISMA on Mental Health
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
ETH Zurich
The University of New South Wales
Conditions:
Psychological Distress
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Given the high prevalence of mental health issues, such as anxiety and depression, in pretrial detainees, the Swiss Federal Justice Department (SFJD) approved a model trial ("Modellversuch Untersuchun...
Detailed Description
The RCT will inform about the effect of PRISMA. The sample size is determined by the enrollment window (from November 27, 2023 to September 30, 2026). Based on historical data, the investigators expe...
Eligibility Criteria
Inclusion
- • Entering pretrial detention inmate in any of the 11 pretrial detention facilities in the Cantons of Zurich and Bern
- aged ≥ 18 years
Exclusion
- Not fluently speaking any of the nine languages in which PRISMA is offered: German, Albanian, Arabic, English, French, Italian, Romanian, Serbian/ Croatian, Spanish
- Acute suicidality
- Not interested in PRISMA and its randomized evaluation
Key Trial Info
Start Date :
January 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2031
Estimated Enrollment :
1480 Patients enrolled
Trial Details
Trial ID
NCT06197711
Start Date
January 22 2024
End Date
June 30 2031
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland, 8006